Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Iradimed übertrifft Q3-Prognosen: Aktie steigt nach starken Zahlen deutlich an/n (Investing.com DE) +++ IRADIMED Aktie -3,09%

MARTENS Aktie

 >MARTENS Aktienkurs 
1.02 EUR    -2.9%    (Tradegate)
Ask: 1.02 EUR / 3113 Stück
Bid: 1.01 EUR / 3185 Stück
Tagesumsatz: 2313 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MARTENS Aktie über LYNX handeln
>MARTENS Performance
1 Woche: -7,1%
1 Monat: -9,6%
3 Monate: +8,9%
6 Monate: +60,0%
1 Jahr: +60,0%
laufendes Jahr: +18,2%
>MARTENS Aktie
Name:  DR. MARTENS PLC LS -,01
Land:  Großbritannien
Sektor:  Konsumgueter / Gastronomie
ISIN/ Wkn:  GB00BL6NGV24 / A2QNAR
Symbol/ Ticker:  3U2 (Frankfurt)
Kürzel:  FRA:3U2, ETR:3U2, 3U2:GR
Index:  -
Webseite:  https://www.drmartens.com..
Profil:  Dr. Martens plc is a renowned footwear manufacture..
>Volltext..
Marktkapitalisierung:  1001.21 Mio. EUR
Unternehmenswert:  1295.4 Mio. EUR
Umsatz:  881.62 Mio. EUR
EBITDA:  149.21 Mio. EUR
Nettogewinn:  5.04 Mio. EUR
Gewinn je Aktie:  0.01 EUR
Schulden:  449.65 Mio. EUR
Liquide Mittel:  174.51 Mio. EUR
Operativer Cashflow:  188.28 Mio. EUR
Bargeldquote:  0.98
Umsatzwachstum:  -8.37%
Gewinnwachstum:  -93.36%
Dividende je Aktie:  0.03 EUR
Dividendenrendite:  2.81%
Dividendenschätzung:  2.81%
Div. Historie:  28.08.25 - 0.0195806€
06.03.25 - 0.0097903€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  MARTENS
Letzte Datenerhebung:  03.11.25
>MARTENS Kennzahlen
Aktien/ Unternehmen:
Aktien: 965.67 Mio. St.
Frei handelbar: 58.6%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 2348
Umsatz/Mitarb.: 0.38 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 7.07%
Bewertung:
KGV: 202.13
KGV lG: 22.78
KUV: 1.19
KBV: 2.45
PEG-Ratio: -
EV/EBITDA: 8.68
Rentabilität:
Bruttomarge: 55.74%
Gewinnmarge: 0.57%
Operative Marge: 7.69%
Managementeffizenz:
Gesamtkaprendite: 0.49%
Eigenkaprendite: 1.23%
>MARTENS Peer Group

Es sind 64 Aktien bekannt.
 
30.10.25 - 18:21
H&M x Glenn Martens: Anstehen für die neue Designer-Kollektion von H&M – wer macht das noch? (Spiegel)
 
Der Modedesigner Karl Lagerfeld entwarf einst Kleidung für H&M, damals ein Tabubruch. Inzwischen kooperiert jeder mit jedem. Jetzt gab es in ausgewählten Geschäften wieder eine Designer-Kollektion. Ein Besuch vor Ort....
29.10.25 - 13:09
John Lapinski Joins Alliant Insurance Services′ Midwest Benefits Team (Business Wire)
 
Veteran consultant to focus on plan design, compliance, cost management, and employee engagementIRVINE, Calif.--(BUSINESS WIRE)--#AlliantInsurance--Alliant Insurance Services continues to add top-tier talent to its Employee Benefits Group in the Midwest, hiring John Lapinski as Senior Vice President. Based in Michigan, Lapinski will serve a diverse client base throughout the Midwest with a focus on plan design, compliance, cost management, and employee engagement. “John is highly adept at leading strategic initiatives that expand market presence and provide exceptional outcomes,” said Greg Martens, Executive Vice President, Alliant Employee Benefits. “His depth of experience will serve as an exceptional asset in delivering optimized solutions for our clients and partners throughout the Midwest.” Lapinski joins Alliant with more than 35 years of experience providing a full range of employee benefits solutions to mid-market and large organizations. His diverse experience includes large group and sel...
02.10.25 - 12:06
Dr Martens strikes deal to enter UAE and grows in Latin America (Alliance)
 
Dr Martens PLC on Thursday announced an expansion in Latin America as well as a distribution deal which will represent its...
24.09.25 - 14:54
Robles BioCeutics Teams Up with Top Tier Intellectual Property Law Firm Knobbe Martens to Protect "First-in-Class" Age Reversing Stem Cell Technology (PR Newswire)
 
Robles BioCeutics' PCT patent application directed to pioneering injury-mimetic stem cell and exosome platform. SAN DIEGO, Sept. 24, 2025 /PRNewswire/ -- Robles BioCeutics, the inventors of the "Injury Mimetic™" approach to stem cell and exosome mediated skin rejuvenation, announced the......
06.08.25 - 17:24
£10,000 in Dr Martens shares at IPO is now worth… (Fool)
 
Dr Martens boots seem as fashionable as ever, but what of the shares in the company? Here's a quick look at how they've fared since listing. The post £10,000 in Dr Martens shares at IPO is now worth… appeared first on The Motley Fool UK....
28.07.25 - 11:12
XFRA: SPAFR - HANDELSUNTERBRECHUNG IN DIVERSEN AUSLANDSAKTIEN - TEIL 1 (XETRA)
 
CA59142H1073 SE0002480442 NZARRE0004S7 AU000000DRO2 NO0011202772 AU0000157679 AU0000367443 CA92905D2032 CA53000A1066 CA21037X1006 CA70337R1073 CA00248Y1079 CA8970021017 AT0000969985 AU0000297962 AU000000DMP0 NZXROE0001S2 SE0001852419 GB00BZ3CNK81 US55302T2042 AU0000241416 CA92865M1023 CA33833X1015 CA50077N1024 AU0000397705 AU000000WBT5 CA22674C1023 JP3128800004 CA56089A4000 CA05455R2081 CA90366H4089 CH0126639464 AU0000035701 CA92847V5018 AU0000221251 NO0010872468 CA46500E8678 AU000000PLS0 AU000000SYR9 AU000000JHX1 NL0000289783 JP3853000002 CA8277191059 CA42249X1006 GB00BKWQ1135 CA7807641062 BMG709641044 CA40066W1068 NL0015000LU4 BMG0403V2062 CA8716261075 FI0009005870 JP3862400003 CA36249G1090 AU000000BRN8 SG2G55000001 CA77273P2017 GB00BJP0B151 NZCNUE0001S2 CH0010675863 AU0000138190 CA8985301008 US25460P2039 CA95556L1013 JP3829750003 CA9638101068 AU000000AKM7 CA74841L1013 GG00B28C2R28 AU000000BRG2 AU0000357261 GB00BNGY4Y86 CA64046G1063...
21.07.25 - 16:06
Inogen Alliance Experts Contribute to Environment Analyst Europe in Focus Industry Report (Accesswire)
 
Holger Hillen, HPC AG; Dieuwke Martens-Bakker, Antea Group Netherlands; Beatrijs Lambie, Antea Group Belgium; and Nan Kjellberg, DGE Sweden. ST. PAUL, MN / ACCESS Newswire / July 21, 2025 / Inogen ......
10.07.25 - 17:00
Dr Martens sees global sales rebound but UK demand remains challenging (DailyMail)
 
The bootmaker noted positive demand in its Americas direct-to-consumer business thanks to full-price retail sales and 'good growth' across the Asia-Pacific....
10.07.25 - 10:48
Dr Martens maintains guidance as financial year starts steadily (Alliance)
 
Dr Martens PLC on Thursday left its guidance unchanged as it said its financial year has started in line with expectations.The London-based bootmaker said it......
10.07.25 - 10:12
Dr Martens tiptoes higher after positive America retail trading, UK still challenging (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
09.07.25 - 20:36
Thursday preview: Foreign trade, Dr.Martens in focus (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
03.07.25 - 10:00
Dr Martens was one of the top-performing UK shares in June. Time to buy? (Fool)
 
Mark Hartley analyses whether Dr Martens' sharp share price rebound makes it one of the UK shares worth considering right now. The post Dr Martens was one of the top-performing UK shares in June. Time to buy? appeared first on The Motley Fool UK....
06.06.25 - 21:00
Berenberg bullish on Dr Martens′ new growth strategy (ShareCast)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
05.06.25 - 23:30
New Dr Martens boss plans revival by focusing on shoes and sandals as well as boots (DailyMail)
 
Ije Nwokorie (pictured), who took over this year, said the 'narrow focus on boots failed to take full advantage' of other areas of the business....
05.06.25 - 16:24
Dr Martens promises not to raise prices this year despite US tariffs (The Guardian)
 
UK footwear brand says it will continue to source bulk of its shoes from Laos and Vietnam 'through tough times'Business live – latest updatesDr Martens has vowed not to increase prices this year and will continue sourcing from Vietnam and Laos, despite the threat of cripplingly high tariffs on the south-east Asian countries, where the bulk of its shoes are made.The British footwear brand, best known for its boots with distinctive yellow stitching, said the majority of its autumn and winter stock would be either in the market or in transit by the start of July, around the time when the 90-day pause on an array of tariffs imposed by the US is due to come to an end. Continue reading......
05.06.25 - 13:09
Dr. Martens plc Non-GAAP EPS of 2.40p, revenue of £787.6M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.06.25 - 12:18
Dr Martens shares soar sharply on profit return expectations, 2025 PBT beat (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.06.25 - 11:00
Dr Martens profit slumps but shares jump on growth outlook (Alliance)
 
Dr Martens PLC on Thursday reported a sharp drop in annual profit due to lower revenue but maintained its full-year dividend and signalled a return......
05.06.25 - 08:45
Bootmaker Dr Martens to cut discounts in Americas and EMEA (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
04.06.25 - 14:12
UK earnings, trading statements calendar - next 7 days (Alliance)
 
Thursday 5 June CMC Markets PLCFull Year ResultsDr Martens PLCFull Year ResultsFevertree Drinks......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer heilt, hat recht. - Hippokrates
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!